BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36790831)

  • 1. Human Papillomavirus Intermittence and Risk Factors Associated With First Detections and Redetections in the Ludwig-McGill Cohort Study of Adult Women.
    Malagón T; Trottier H; El-Zein M; Villa LL; Franco EL;
    J Infect Dis; 2023 Aug; 228(4):402-411. PubMed ID: 36790831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil. Ludwig-McGill Study Group.
    Franco E; Villa L; Rohan T; Ferenczy A; Petzl-Erler M; Matlashewski G
    Rev Panam Salud Publica; 1999 Oct; 6(4):223-33. PubMed ID: 10572472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Episodic detection of human papillomavirus within a longitudinal cohort of young women.
    Shew ML; Ermel AC; Tong Y; Tu W; Qadadri B; Brown DR
    J Med Virol; 2015 Dec; 87(12):2122-9. PubMed ID: 26112742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incident Detection of High-Risk Human Papillomavirus Infections in a Cohort of High-Risk Women Aged 25-65 Years.
    Winer RL; Hughes JP; Feng Q; Stern JE; Xi LF; Koutsky LA
    J Infect Dis; 2016 Sep; 214(5):665-75. PubMed ID: 27009602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimising follow-up strategy based on cytology and human papillomavirus after fertility-sparing surgery for early stage cervical cancer: a nationwide, population-based, retrospective cohort study.
    Schuurman TN; Schaafsma M; To KH; Verhoef VMJ; Sikorska K; Siebers AG; Wenzel HHB; Bleeker MCG; Roes EM; Zweemer RP; de Vos van Steenwijk PJ; Yigit R; Beltman JJ; Zusterzeel PLM; Lok CAR; Bekkers RLM; Mom CH; van Trommel NE
    Lancet Oncol; 2023 Dec; 24(12):1349-1358. PubMed ID: 37952541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
    Gilham C; Sargent A; Kitchener HC; Peto J
    Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV genotype distribution in Brazilian women with and without cervical lesions: correlation to cytological data.
    Martins TR; Mendes de Oliveira C; Rosa LR; de Campos Centrone C; Rodrigues CL; Villa LL; Levi JE
    Virol J; 2016 Aug; 13():138. PubMed ID: 27515763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus infections with multiple types and risk of cervical neoplasia.
    Trottier H; Mahmud S; Costa MC; Sobrinho JP; Duarte-Franco E; Rohan TE; Ferenczy A; Villa LL; Franco EL
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1274-80. PubMed ID: 16835323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.
    Verguts J; Bronselaer B; Donders G; Arbyn M; Van Eldere J; Drijkoningen M; Poppe W
    BJOG; 2006 Nov; 113(11):1303-7. PubMed ID: 16978225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No association between endogenous retinoic acid and human papillomavirus clearance or incident cervical lesions in Brazilian women.
    Siegel EM; Salemi JL; Craft NE; Villa LL; Ferenczy AS; Franco EL; Giuliano AR
    Cancer Prev Res (Phila); 2010 Aug; 3(8):1007-14. PubMed ID: 20606041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proportion of Incident Genital Human Papillomavirus Detections not Attributable to Transmission and Potentially Attributable to Latent Infections: Implications for Cervical Cancer Screening.
    Malagón T; MacCosham A; Burchell AN; El-Zein M; Tellier PP; Coutlée F; Franco EL;
    Clin Infect Dis; 2022 Aug; 75(3):365-371. PubMed ID: 34849640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of Human Papillomavirus Genotyping before and after Cervical Conization for Squamous Intraepithelial Lesion.
    Iida Y; Sato S; Okawa M; Hikino K; Komatsu H; Kudoh A; Chikumi J; Oishi T; Harada T; Taniguchi F
    Acta Cytol; 2023; 67(1):17-26. PubMed ID: 36310011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016.
    Ouh YT; Min KJ; Cho HW; Ki M; Oh JK; Shin SY; Hong JH; Lee JK
    J Gynecol Oncol; 2018 Jan; 29(1):e14. PubMed ID: 29185272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia.
    Schlecht NF; Kulaga S; Robitaille J; Ferreira S; Santos M; Miyamura RA; Duarte-Franco E; Rohan TE; Ferenczy A; Villa LL; Franco EL
    JAMA; 2001 Dec; 286(24):3106-14. PubMed ID: 11754676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproductive and genital health and risk of cervical human papillomavirus infection: results from the Ludwig-McGill cohort study.
    Shaw E; Ramanakumar AV; El-Zein M; Silva FR; Galan L; Baggio ML; Villa LL; Franco EL;
    BMC Infect Dis; 2016 Mar; 16():116. PubMed ID: 26956880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High risk human papillomavirus prevalence and genotype distribution among women infected with HIV in Manaus, Amazonas.
    Teixeira MF; Sabidó M; Leturiondo AL; de Oliveira Ferreira C; Torres KL; Benzaken AS
    Virol J; 2018 Feb; 15(1):36. PubMed ID: 29454382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Human Papillomavirus (HPV) Infection and Cervical Neoplasia after Pregnancy.
    Trottier H; Mayrand MH; Baggio ML; Galan L; Ferenczy A; Villa LL; Franco EL;
    BMC Pregnancy Childbirth; 2015 Oct; 15():244. PubMed ID: 26446835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of high-risk Human Papillomavirus genotyping in cervical disease in the Northern region of Portugal: Real-world data from regional cervical cancer screening program.
    Rosário A; Sousa A; Marinho-Dias J; Medeiros R; Lobo C; Leça L; Coimbra N; Tavares F; Baldaque I; Martins G; Monteiro P; Henrique R; Sousa H
    J Med Virol; 2023 Jan; 95(1):e28414. PubMed ID: 36541747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus genotype distribution in cervical samples collected in routine clinical practice at the Nantes University Hospital, France.
    Vaucel E; Coste-Burel M; Laboisse C; Dahlab A; Lopes P
    Arch Gynecol Obstet; 2011 Oct; 284(4):989-98. PubMed ID: 21107591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.